CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy. Issue 1 (31st January 2022)

• Record Type: Journal Article
• Authors: Billmeier, Arne; Khinvasara, Krutika; Lang, Franziska; Mohr, Julia; Reidenbach, Daniel; Schork, Maik; Yildiz, Ikra; Diken, Mustafa
• Is Part Of: Human vaccines & immunotherapeutics. Volume 18:Issue 1(2022)
• Publication Date: 2022-01-31
• Subjects: CIMT -- cancer immunotherapy -- tumor vaccination -- cellular therapy -- combination therapy -- tumor microenvironment -- checkpoint blockade -- personalized therapy -- Covid19; Vaccines -- Periodicals; 615.372
• DOI: 10.1080/21645515.2021.2024416
• Languages: English
• ISSNs: 2164-5515

Abstract

ABSTRACT: After one year of absence, the 18th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe's cancer immunotherapy meeting, took place virtually from 10 to 12 May 2021. Over 850 academic and clinical professionals from 30 countries met to discuss the recent advancements in cancer immunotherapy and the current progress in COVID19-related research. This meeting report summarizes the highlights of CIMT2021.